What is Wolfe Research’s Forecast for Teleflex Q4 Earnings?

Teleflex Incorporated (NYSE:TFX) – Equities research analysts at Wolfe Research reduced their Q4 2025 earnings per share estimates for Teleflex in a research report issued on Wednesday, November 12th. Wolfe Research analyst M. Polark now expects that the medical technology company will post earnings per share of $3.84 for the quarter, down from their prior estimate of $3.89. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Wolfe Research also issued estimates for Teleflex’s FY2029 earnings at $21.27 EPS.

A number of other research analysts have also recently commented on TFX. Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday. Zacks Research downgraded shares of Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Wells Fargo & Company cut their price objective on Teleflex from $131.00 to $114.00 and set an “equal weight” rating for the company in a report on Friday, November 7th. Truist Financial cut their target price on shares of Teleflex from $128.00 to $120.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Finally, Royal Bank Of Canada reduced their price target on shares of Teleflex from $135.00 to $120.00 and set a “sector perform” rating on the stock in a research report on Friday, November 7th. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Teleflex currently has an average rating of “Reduce” and a consensus target price of $134.57.

Teleflex Stock Down 3.0%

Teleflex stock opened at $103.83 on Monday. Teleflex has a twelve month low of $102.58 and a twelve month high of $195.47. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The firm has a 50 day moving average price of $123.31 and a 200-day moving average price of $121.91. The company has a market capitalization of $4.59 billion, a P/E ratio of 24.43, a P/E/G ratio of 1.79 and a beta of 1.05.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business’s revenue was up 19.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is currently -18.50%.

Institutional Investors Weigh In On Teleflex

Hedge funds have recently made changes to their positions in the company. NorthCrest Asset Manangement LLC bought a new stake in Teleflex during the second quarter worth about $299,000. Speece Thorson Capital Group Inc. raised its stake in Teleflex by 2.4% during the 2nd quarter. Speece Thorson Capital Group Inc. now owns 89,843 shares of the medical technology company’s stock valued at $10,634,000 after buying an additional 2,096 shares during the last quarter. CWM LLC lifted its stake in shares of Teleflex by 160.8% in the 2nd quarter. CWM LLC now owns 11,904 shares of the medical technology company’s stock worth $1,409,000 after purchasing an additional 7,340 shares during the period. Teacher Retirement System of Texas raised its position in Teleflex by 31.5% in the second quarter. Teacher Retirement System of Texas now owns 11,819 shares of the medical technology company’s stock worth $1,399,000 after acquiring an additional 2,831 shares during the period. Finally, Northwestern Mutual Wealth Management Co. lifted its position in Teleflex by 30.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 556 shares of the medical technology company’s stock valued at $77,000 after purchasing an additional 129 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.